Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Large B-Cell, Diffuse × Thiotepa × Clear all

Phase

Status

Completed 8 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Myelodysplastic Syndromes 6 Leukemia, Myeloid, Acute 6 Hematologic Neoplasms 4 Myeloproliferative Disorders 3 Neuroblastoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Graft vs Host Disease 2 Burkitt Lymphoma 2 Teratoma 1 Recurrence 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Mast-Cell 1 Leukemia, Lymphoid 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 High Risk Myeloid Malignancies 1 Ganglioneuroblastoma 1 GATA2 Deficiency 1 Choriocarcinoma 1 Carcinoma, Embryonal 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

Cyclophosphamide 32 Rituximab 31 Magnetic Resonance Spectroscopy 16 Doxorubicin 16 Lenalidomide 15 Specimen Handling 14 Prednisone 14 polatuzumab vedotin 13 fludarabine 13 Vincristine 10 Oxaliplatin 10 Gemcitabine 10 Biopsy 10 zanubrutinib 9 Etoposide 9 glofitamab 7 axicabtagene ciloleucel 7 Immunotherapy, Adoptive 6 tafasitamab 5 loncastuximab tesirine 5 fludarabine phosphate 5 acalabrutinib 5 Prednisolone 5 Leukapheresis 5 Injections 5 Ifosfamide 5 tisagenlecleucel 4 orelabrutinib 4 obinutuzumab 4 Carboplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06687772 2025-10-27

CNS-PHLAT

Washington University School of Medicine

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡